After restricting the sample to those with BRAF-mutant versus RET/NTRK fusion status, statistically significant associations were still found among age, AJCC N (lymph node metastasis) and M (distant metastasis, all pulmonary) categories as well as remission at 1 year (P value < .05). The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.